Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page history. This appears to be a minor site version update with no substantive changes to study data or navigation.
    Difference
    0.0%
    Check dated 2026-02-11T11:52:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-04T10:27:17.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary visibility controls and color-coded highlights for additions and deletions were added to the study history page. Revision notes now show 'Revision: v3.4.0', and 'No FEAR Act Data' was removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:16.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.4, replacing v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:51:30.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the footer, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-23T21:12:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The history version now includes new core content sections: Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Arms and Interventions, and Study Status. These updates expand the data on safety, outcomes, and trial design for NCT03924869 (version dated 2025-12-11, preceding version 2025-11-24, entry 167).
    Difference
    0.2%
    Check dated 2025-12-16T18:56:57.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.